Kathleen Ragelis

Tafkak, Inc. provides genome sequencing and analysis solutions. It offers tools and solutions to researchers, drug developers and clinicians determine the genetic basis of human disease and drug response. The firm provides knomeCLINIC a software suite that helps medical researchers and clinicians interpret human genomes for biological relevance; kGAP a cloud-enabled genome informatics engine that automates the process of standardizing, distilling, annotating and comparing sequence data. It also offers knomeVARIANTS, a discovery-supportive interpretation tool, which helps researchers to find causal variants and genes. The company was founded by Jorge Conde and George M. Church in 2007 and is headquartered in Waltham, MA.

Pluralsight LLC engages in online development and IT training services. Its platform includes browse library, plural Insight IQ, paths, mentoring, mobile apps, and professional services. The firm serves the individuals, small business, academic, federal government, and state and local government. The company was founded by Keith Sparkjoy, Fritz Onion, Keith Brown, Bill Williams and Aaron Skonnard in 2004 and is headquartered in Farmington, UT.

Syneos Health Consulting, Inc. provides consulting services to pharmaceutical and biotech industries. It is organized into practice areas, each specializing in a critical industry function: brand management, business development, clinical development, managed markets, medical affairs, sales, and trade and distribution. The company was founded by John J. Campbell in 1997 and is headquartered in Morrisville, NC.

Summus Global, Inc. is a virtual health advisory platform that connects families to a network of over 4,000 top specialists across 48 leading hospitals worldwide. The company is based in New York, NY. The company aims to provide a faster and more efficient way to access high-quality medical expertise, transforming the existing inefficient and opaque referral system. Summus partners with companies across the country to create an elevated healthcare experience for their employees and to support better, cost-efficient outcomes across all health questions. The company was founded by Julian Flannery, Aftab R. Kherani, and Jennifer Kherani, and Julian Flannery has been the CEO since incorporation.

SamaCare, Inc. engages in manufacture of physician administered drugs. The company was founded by Syam Palakurthy and Scott Zhang in 2018 and is headquartered in San Francisco, CA.

Millennium TVP Management Co LLC (Millennium TVP Mgmt) is a private equity firm founded in 1996 by Samuel Schwerin and Dan Burstein. The firm is headquartered in New York.

RedLock LLC provides deep security visibility and predictive analytics for modern IT infrastructure. It enables enterprises to securely adopt IaaS platforms like AWS and Azure. The firm provides agentlless architecture, 360 degree security, policy orchestration and multi-cloud support services. The company was founded by Varun Badhwar and Gaurav Kumar in 2015 and is headquartered in Menlo Park, CA.

Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

McKinsey & Co., Inc. is an American company that provides management consulting services. The private company is based in California.

AH Capital Management LLC (AH Capital Management) is a venture capital firm founded in 2009 by Marc Lowell Andreessen and Ben A. Horowitz. The firm is headquartered in Menlo Park, California.

MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.

Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom.

Zephyr Health, Inc. provides cloud-based solutions for health companies. Zephyr health helps life sciences companies organize and visualize global health data to connect their therapies to people in need. It offers medical affairs, marketing, sales and technology solutions. The company was founded by William King in May 2011 and is headquartered in San Francisco, CA.

twoXAR, Inc. provides drug discovery services. Its DUMA platform rapidly evaluates massive public and proprietary datasets to identify and rank probability drug-disease matches. The company was founded by Andrew A. Radin and Andrew M. Radin in 2014 and is headquartered in Palo Alto, CA.

Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA.

Octant, Inc. operates as a biotechnology company. The company was founded by Sri Kosuri and Ramsey Homsany and is headquartered in Emeryville, CA.

Dyno Therapeutics, Inc. engages in the development of therapeutics technologies. It develops technologies for safe, efficient and targeted in vivo delivery of new gene therapies and genome editing therapies. The company was founded by Kelsic Eric David and is headquartered in Watertown, MA.

Asimov, Inc. develops and operates software platform for biotechnology. Its platform combines computer-aided design, artificial intelligence, and synthetic biology. The company was founded by Christopher Voigt, Douglas Densmore, Alec Neilson, and Raja Srinivas on March 27, 2017 and is headquartered in Cambridge, MA.

IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation.